Literature DB >> 3435929

Circadian and ultradian rhythms of proliferation in human ovarian cancer.

R R Klevecz1, P S Braly.   

Abstract

Synchronous waves of proliferation in tumor cells taken from patients with ovarian cancer were observed using flow cytometry to measure the fraction of cells undergoing DNA replication and displaying tumor-cell-specific immunofluorescence. When saline washings of the abdominal cavity were analyzed at 2-4 hr intervals round-the-clock, the percentage of cells in the chromosome replication cycle (S + G2 percentage) showed 12-hr and often higher frequency rhythms in proliferation. These higher frequency rhythms in DNA replication show a relatively constant phase relationship to the patient's circadian clock with peak proliferation occurring most commonly at 10 a.m. to 12 noon and again at 10 p.m. This proliferation rhythm is therefore partially out of phase with the 24-hr rhythms in proliferation seen in normal cells. The findings on human cancer reveal a fundamental difference in the temporal organization of normal and tumor cell growth that should be exploited for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435929     DOI: 10.3109/07420528709078543

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  4 in total

1.  Differential replication timing of X-linked genes measured by a novel method using single-nucleotide primer extension.

Authors:  Z Xiong; W Tsark; J Singer-Sam; A D Riggs
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

2.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31

3.  Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice.

Authors:  Susie Lee; Lawrence A Donehower; Alan J Herron; David D Moore; Loning Fu
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

Review 4.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.